Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 4.6B | 4.3B | 4.9B | 4.0B |
Cost of revenue | 2.3B | 2.3B | 2.6B | 2.5B |
Gross profit | 2.3B | 2.0B | 2.2B | 1.4B |
Operating expense | ||||
Research & development | 34.4M | 37.0M | 41.3M | 40.4M |
Selling general and admin | 81.7M | 94.6M | 110.1M | 97.2M |
Other operating expenses | 123.8M | 122.1M | 73.9M | 177.1M |
Operating income | 2.1B | 1.7B | 2.0B | 1.1B |
Non operating interest income | ||||
Income | 46.4M | 35.3M | 32.7M | 31.8M |
Expense | 55.9M | 67.9M | 80.0M | 73.9M |
Other income expense | 612.2M | 423.9M | -172.8M | -163.4M |
Pretax income | 2.7B | 2.1B | 1.8B | 910.5M |
Tax provision | 938.9M | 556.3M | 603.6M | 209.8M |
Net income | 1.8B | 1.6B | 1.2B | 794.5M |
Basic EPS | 1.9 | 1.7 | 1.2 | 0.8 |
Diluted EPS | 1.9 | 1.7 | 1.2 | 0.8 |
Basic average shares | 954.4M | 968.1M | 974.2M | 986.2M |
Diluted average shares | 956.1M | 969.0M | 975.9M | 987.9M |
EBITDA | 2.6B | 2.3B | 2.6B | 1.7B |
Net income from continuing op. | 1.8B | 1.6B | 1.2B | 794.5M |
Minority interests | -12.0M | -9.5M | -15.5M | -1.7M |
Preferred stock dividends | — | — | — | — |